← Screener

ABTAbbott Laboratories

Health care · Pharmaceuticals · NYSE

Compare with peers → Embed

Filings with the SEC since Jul 12, 2018

1,003 filings, 5 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Feb 20, 2026

10-K, period to Dec 31, 2025

Latest quarterly reportOpen ↗

Nov 4, 2026

10-Q, period to Sep 30, 2026

Latest current reportOpen ↗

Oct 21, 2026

8-K: Quarterly results

Filed in the last 30 days

of 1,003 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 36 events

Nov 4, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Oct 31, 2026SEC letter SEC asked 9 questions about Form 10-K for the Fiscal Year Ended December 31, 2020 letters 2021-09-21 to 2022-02-11 · Climate, Results discussion (MD&A), Legal and contingencies
Oct 21, 20268-K Quarterly results 8-K item 2.02
Oct 21, 20268-K Other events 8-K item 8.01
Aug 20, 20268-K Regulation FD disclosure, Other events 8-K items 7.01, 8.01
Jul 28, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
Jul 16, 20268-K Quarterly results 8-K item 2.02
Jun 18, 2026Buy Stratton John G (Director) bought $174K open-market purchase on May 7, 2026
Jun 18, 2026Cluster buy Cluster buy: 3 insiders bought $1.3M 2026-04-23 to 2026-05-07: STARKS DANIEL J, Boudreau Philip P, Stratton John G
Apr 29, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
Apr 28, 2026Buy STARKS DANIEL J (Director) bought $927K open-market purchase on Apr 27, 2026
Apr 27, 2026Buy Boudreau Philip P (EVP AND CFO) bought $201K open-market purchase on Apr 23, 2026
Apr 27, 20268-K Director or officer change, Bylaws or fiscal year changed, Shareholder vote results 8-K items 5.02, 5.03, 5.07
Apr 17, 20268-K Other events 8-K item 8.01
Apr 16, 20268-K Quarterly results 8-K item 2.02
Mar 23, 20268-K Other events 8-K item 8.01
Mar 9, 20268-K Material agreement signed, New debt or obligation 8-K items 1.01, 2.03
Feb 26, 20268-K Material agreement signed 8-K item 1.01
Feb 23, 2026Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · Abbott may offer from time to time, either separately or together, debt securities, common shares, preferred shares, depositary shares, warrants, purchase contracts, and units (collectively, the “securities”).
Feb 20, 20268-K Bylaws or fiscal year changed 8-K item 5.03
Feb 20, 202610-K Annual report (10-K) period ended Dec 31, 2025
Jan 22, 20268-K Quarterly results 8-K item 2.02
Dec 12, 20258-K Director or officer change, Bylaws or fiscal year changed 8-K items 5.02, 5.03
Nov 21, 20258-K Item 5.04 8-K item 5.04
Nov 20, 20258-K Material agreement signed, Regulation FD disclosure, Other events 8-K items 1.01, 7.01, 8.01
Oct 29, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Oct 15, 20258-K Quarterly results 8-K item 2.02
Jul 30, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
Jul 17, 20258-K Quarterly results 8-K item 2.02
May 1, 20258-K Director or officer change 8-K item 5.02
Apr 30, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
Apr 28, 20258-K Shareholder vote results 8-K item 5.07
Apr 16, 20258-K Quarterly results 8-K item 2.02
Feb 21, 202510-K Annual report (10-K) period ended Dec 31, 2024
Jan 22, 20258-K Quarterly results 8-K item 2.02
Nov 15, 20248-K Director or officer change 8-K item 5.02

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1003 Annual & quarterly 34 Current reports (8-K) 90 Insiders 793 Proxy & votes 25 Big owners (13D/13G) 19 Shares & debt offered 16 SEC letters 6 Other 20

Filed	Form	What it is	Period
Mar 13, 2026	DEFA14A	Extra proxy material		all files
Mar 13, 2026	DEF 14A	Proxy statement	Apr 24, 2026	all files
Mar 14, 2025	DEFA14A	Extra proxy material		all files
Mar 14, 2025	DEF 14A	Proxy statement	Apr 25, 2025	all files
Mar 15, 2024	DEFA14A	Extra proxy material		all files
Mar 15, 2024	DEF 14A	Proxy statement	Apr 26, 2024	all files
Apr 10, 2023	PX14A6G	Shareholder's proxy letter		all files
Apr 5, 2023	PX14A6G	Shareholder's proxy letter		all files
Mar 17, 2023	DEFA14A	Extra proxy material		all files
Mar 17, 2023	DEF 14A	Proxy statement		all files
Mar 25, 2022	PX14A6G	Shareholder's proxy letter		all files
Mar 24, 2022	PX14A6G	Shareholder's proxy letter		all files
Mar 21, 2022	PX14A6G	Shareholder's proxy letter		all files
Mar 18, 2022	DEFA14A	Extra proxy material		all files
Mar 18, 2022	DEF 14A	Proxy statement	Apr 29, 2022	all files
Mar 17, 2021	PX14A6G	Shareholder's proxy letter		all files
Mar 12, 2021	DEFA14A	Extra proxy material		all files
Mar 12, 2021	DEF 14A	Proxy statement	Apr 23, 2021	all files
Feb 25, 2021	PRE 14A		Apr 23, 2021	all files
Apr 14, 2020	DEFA14A	Extra proxy material		all files
Mar 24, 2020	PX14A6G	Shareholder's proxy letter		all files
Mar 13, 2020	DEFA14A	Extra proxy material		all files
Mar 13, 2020	DEF 14A	Proxy statement	Apr 24, 2020	all files
Mar 15, 2019	DEFA14A	Extra proxy material		all files
Mar 15, 2019	DEF 14A	Proxy statement	Apr 26, 2019	all files

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →